author-photo

Saran Vardhanabhuti

Takeda Pharmaceutical Company

3

Papers

119

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Sample Size Determination Under Non-proportional Hazards

2019
Show All
- Source
- Cite
- Save
Citations (2)
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML

2018 Blood
Show All
- Source
- Cite
- Save
Citations (110)
Results of a Clinical Study of Pevonedistat (Pev), a First-in-Class NEDD8-Activating Enzyme (NAE) Inhibitor, Combined with Azacitidine (Aza) in Older Patients (Pts) with Acute Myeloid Leukemia (AML)

2016 Blood
Show All
- Source
- Cite
- Save
Citations (7)